Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

People with allergies warned not to eat imported Dubai-style chocolate products  12th June 2025

The Food Standards Agency (FSA) is warning people with allergies to be cautious when buying imported Dubai-style chocolate as some products may not have clear or reliable labels.  
[…]

Read more
Celebrating an allergy-safe Father’s Day: Fun and safe ideas for the whole family  12th June 2025

Father’s Day is a chance to celebrate everything that makes your dad special. If food allergies are part of your life, the day might take a little more planning—but that doesn’t mean it has to be any less memorable.  Whether
[…]

Read more
Flying with allergies: our top tips   11th June 2025

With summer holidays just around the corner, many of us are preparing for exciting trips away. But for those living with allergies, the thought of travelling can bring additional stress and anxiety. If you or a loved one has serious
[…]

Read more

News Type:

Dr. William Frankland MBE, Honorary President of the Anaphylaxis Campaign, celebrates 108th birthday 19th March 2020

The Anaphylaxis Campaign would like to wish its Honorary President, Dr. William Frankland MBE, a very happy 108th birthday. Throughout his life, Dr. Frankland has worked to improve the lives of others and for more than 50 years, he has

Read more
The Anaphylaxis Campaign and Covid-19 17th March 2020

We have been closely monitoring the developing COVID-19 outbreak and want to reassure you that we are making plans to ensure we can continue to operate as usual and provide our much-needed services and resources to anyone who needs them.

Read more
Statement regarding death of Nicholas Kelly 12th March 2020

We are saddened to learn of the tragic death of Nicholas Kelly, aged 16, due to a suspected allergic reaction, and would like to offer our deepest sympathies to his family at this difficult time. We have very little detail

Read more
MHRA issues important alert for Emerade 150/300/500mcg auto-injectors 4th March 2020

4th March 2020 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that makes Emerade pens about the defect previously reported by the MHRA. The defect means some pens may

Read more
Survey: Making allergy, skin disease and asthma care better for young people 28th February 2020

Developing new guidance for healthcare professionals looking after teenagers and young adults with allergies and/or asthma. It is important that young people learn how to self-manage their allergies and/or asthma. Adolescence can be a challenging time for them and their

Read more
Food Standards Agency Survey: Improving life for people with Food Hypersensitivity 21st February 2020

The Food Standards Agency (FSA) are inviting those affected or interested in food hypersensitivity to participate in an online survey and share their experiences. Around 2% of adults and 8% of children in the UK have a food hypersensitivity. This

Read more
Latest statement on availability of EpiPen® 0.3mg and 0.15mg Adrenaline Auto-Injectors 14th February 2020

The Anaphylaxis Campaign has received the following updated statement from Mylan regarding the availability of EpiPen. This includes information for patients, prescribers, pharmacists, hospitals and schools. Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has

Read more
Statement regarding the death of Sam Collings 13th February 2020

The Anaphylaxis Campaign is saddened to learn of the death of Sam Collings, aged 19,  who died at Bolton Hospital on the 4th August 2019. According to media reports, neither Sam or his family had suspected that Sam suffered from

Read more
First Oral Immunotherapy Drug ‘Palforzia’ gets FDA Approval 3rd February 2020

The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has

Read more